Kweichow Moutai (600519.SH) has repurchased a total of 416,900 shares, costing 571 million yuan.

19:14 03/02/2026

Guizhou Maotai (600519.SH) announced that as of the end of January 2026, the company has repurchased a total of 416,900 shares, accounting for 0.0333% of the total share capital. The highest purchase price was 1,418.37 yuan per share, the lowest purchase price was 1,322.60 yuan per share, and the total amount paid was 571 million yuan (excluding transaction fees).

Kweichow Moutai (600519.SH) announced that as of the end of January 2026, the company has repurchased a total of 416,900 shares, accounting for 0.0333% of the total share capital. The highest price purchased was 1,418.37 yuan/share and the lowest price was 1,322.60 yuan/share, with a total amount paid of 571 million yuan (excluding transaction fees).

QIDIAN GUOFENG (01280) completes issuance of 1.975 million shares to acquire AI company

The innovative drug CMS-D017 capsule developed independently by CMS(00867) has obtained the approval notification for clinical trial of drugs for renal diseases mediated by complement participation adaptation.

GF SEC(01776): "25 GF D8" will be issued on February 5th with dividends and delisting.

QIDIAN GUOFENG (01280) completes issuance of 1.975 million shares to acquire AI company

GF SEC(01776): "25 GF D8" will be issued on February 5th with dividends and delisting.